EGFR and mTOR as therapeutic targets in glioblastoma

Oncotarget. 2019 Jul 30;10(46):4721-4723. doi: 10.18632/oncotarget.27094.

Authors

Michael W Ronellenfitsch¹, Anna-Luisa Luger¹, Joachim P Steinbach¹

Affiliation

¹ Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Cancer Consortium, Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany; Frankfurt Cancer Institute, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.

No abstract available

Keywords: DDIT4; EGFR; glioblastoma; mTOR; tumor microenvironment.

Publication types

Editorial